结论：特布他林加赛庚啶治疗婴儿气喘和咳嗽的安全性强、疗效较好。
CONCLUSION: Terbutaline plus cyproheptadine is safe and efficient for treatment of asthma and cough in infants.
纳入比较鼻内皮质类固醇及鼻内安慰剂或其他传统气喘治疗的随机对照试验。
Randomised controlled trials comparing intranasal corticosteroids to intranasal placebo or to other traditional asthma treatments were included.
基因表现型态将可能有助于把患有气喘、尿病或肥胖的病人分成子群，各自有不同的治疗之需。
Expression profiling might help distinguish subgroups of patients with such disorders as asthma, diabetes or obesity who have special treatment needs.
应用推荐